FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "QuVa Pharma, Inc.(036662848)" | Ephedrine Sulfate | 25 mg/5 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ephedrine Sulfate | 50 mg/10 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ephedrine Sulfate | 150000 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ephedrine Sulfate | 50 mg/10 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Epinephrine | 100 ug/10 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Fentanyl | 30000 ug/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Fentanyl | 60000 ug/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Fentanyl Citrate | 2000 ug/100 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Fentanyl Citrate | 2500 ug/250 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Fentanyl Citrate | 1000 ug/100 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Amiodarone | 5400 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Amiodarone Hydrochloride | 450 mg/250 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Amiodarone Hydrochloride | 900 mg/500 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Heparin | 50 U/50 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Hydromorphone Hydrochloride | 3000 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Hydromorphone Hydrochloride | 600 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Hydromorphone Hydrochloride | 10 mg/50 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Hydromorphone Hydrochloride | 6 mg/30 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Hydromorphone Hydrochloride | 50 mg/50 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ketamine | 30000 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ketamine Hydrochloride | 50 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ketamine Hydrochloride | 50 mg/5 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ketamine Hydrochloride | 75000 mg/1500 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ketamine Hydrochloride | 20 mg/2 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Labetalol | 15000 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Labetalol Hydrochloride | 20 mg/4 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine | 100 mg/10 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine | 100 mg/5 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine | 60000 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine | 3334 mg/2000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine | 30000 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine | 10 mg/100 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine; Epinephrine | 15 mg/3 mL; 30 ug/3 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine; Epinephrine | 15000 mg/3000 mL; 30 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine; Epinephrine | 30 mg/3 mL; 30 ug/3 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine; Epinephrine | 30000 mg/3000 mL; 30000 ug/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Morphine | 50 mg/50 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Morphine Sulfate | 30 mg/30 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Morphine Sulfate | 1500 mg/1500 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Morphine Sulfate | 3000 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Neostigmine | 3000 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Neostigmine | 5 mg/5 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 4 mg/250 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 3000 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 16 mg/250 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 8 mg/250 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 20 U/1000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 22500 U/2250 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 10020 U/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 500000 U/500 mL | 2025-1 | source_no_ndc | 2026-10-17 |